Loading the company…
Loading the company…
Families: Debridement & negative-pressure wound therapy, Skin substitutes & wound grafts.
All companies · Product and company coverage
In the last ten years FDA made 4 decisions for Zhejiang Longterm Medical Technology (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2022 (1). The latest was on 2022-05-31.
| Family | Decisions on record |
|---|---|
| Debridement & negative-pressure wound therapy | 3 |
| Skin substitutes & wound grafts | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2022-05-31 | 510(k) | K211571 | Small Foam Kit, Medium Foam Kit, Large Foam Kit, Extra Large Foam Kit |
| 2021-12-15 | 510(k) | K202823 | Innomed NPWT Silicone Foam Dressing |
| 2020-06-17 | 510(k) | K192478 | LT Antibacterial Alginate with Silver Dressing |
| 2019-05-23 | 510(k) | K182458 | Longterm NPWT Foam Dressing Kit |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Zhejiang Longterm Medical Technology.